Literature DB >> 9854058

E test versus agar dilution for antimicrobial susceptibility testing of viridans group streptococci.

S J Rosser1, M J Alfa, S Hoban, J Kennedy, G K Harding.   

Abstract

Viridans group streptococci (VGS) are commonly isolated from the blood of hospitalized patients. The E test represents a convenient method for determining the MICs for VGS, but for this purpose it has not been well validated against reference methods. In this study, 180 unselected VGS isolates were identified to a species level, and the MICs of penicillin, cefuroxime, cefotaxime, and vancomycin were determined by both agar dilution and the E test. Available data regarding demographic and laboratory variables for each VGS bacteremic episode were collected, the significance of each VGS isolate was assessed, and the associations between and among laboratory and clinical variables were investigated. Among all VGS isolates, 68.3% (median of three runs) were found to be fully susceptible to penicillin by agar dilution. The E test and agar dilution showed average agreements (within +/-1 dilution) of 92.2% for penicillin, 95.7% for cefuroxime 91.3% for cefotaxime, and 86.7% for vancomycin. Agreements over serial E tests and serial agar dilutions were excellent for beta-lactam agents (intraclass correlation coefficients, >0.9) but less impressive for vancomycin. Very major error rates for the E test were </=0.7%, and combined major and minor error rates were within acceptable limits for all antimicrobial agents tested. Lysis-centrifugation culture methods were more often associated with clinically insignificant VGS isolates; otherwise, no associations between clinical and laboratory variables were noted.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9854058      PMCID: PMC84157     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  Measurement of antimicrobial susceptibility among invasive isolates of Streptococcus pneumoniae: comparison of the Etest with the standard agar dilution method.

Authors:  M A Fitzgerald; A J Parkinson
Journal:  Alaska Med       Date:  1997 Jan-Mar

2.  The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults.

Authors:  M P Weinstein; M L Towns; S M Quartey; S Mirrett; L G Reimer; G Parmigiani; L B Reller
Journal:  Clin Infect Dis       Date:  1997-04       Impact factor: 9.079

3.  Emerging multiply resistant enterococci among clinical isolates. II. Validation of the etest to recognize glycopeptide-resistant strains.

Authors:  R N Jones; M E Erwin; S C Anderson
Journal:  Diagn Microbiol Infect Dis       Date:  1995-02       Impact factor: 2.803

4.  Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer.

Authors:  J Carratalá; F Alcaide; A Fernández-Sevilla; X Corbella; J Lińares; F Gudiol
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079

5.  Comparison of E test with standard broth microdilution for determining antibiotic susceptibilities of penicillin-resistant strains of Streptococcus pneumoniae.

Authors:  E A Macias; E O Mason; H Y Ocera; M T LaRocco
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

6.  Evaluation of E test as a rapid method for determining MICs for nutritionally variant streptococci.

Authors:  C P Douglas; S Siarakas; T Gottlieb
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

7.  Clinical comparison of isolator and thiol broth with ESP aerobic and anaerobic bottles for recovery of pathogens from blood.

Authors:  J A Kellogg; D A Bankert; J P Manzella; K S Parsey; S L Scott; S H Cavanaugh
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

8.  Prevalence of penicillin-resistant viridans streptococci in healthy children and in patients with malignant haematological disorders.

Authors:  H F Guiot; L J Corel; J M Vossen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-08       Impact factor: 3.267

9.  Identification of viridans streptococci associated with bacteraemia in neutropenic cancer patients.

Authors:  D Beighton; A D Carr; B A Oppenheim
Journal:  J Med Microbiol       Date:  1994-03       Impact factor: 2.472

10.  Viridans streptococcal bacteraemia in patients with neutropenia.

Authors:  P Richard; G Amador Del Valle; P Moreau; N Milpied; M P Felice; T Daeschler; J L Harousseau; H Richet
Journal:  Lancet       Date:  1995-06-24       Impact factor: 79.321

View more
  3 in total

1.  Discrepancy in antimicrobial susceptibility test results obtained for oral streptococci with the Etest and agar dilution.

Authors:  Eiman M Mokaddas; Nathaneal O Salako; Leeba Philip; Vincent O Rotimi
Journal:  J Clin Microbiol       Date:  2007-05-02       Impact factor: 5.948

2.  Bloodstream and endovascular infections due to Abiotrophia defectiva and Granulicatella species.

Authors:  Laurence Senn; José M Entenza; Gilbert Greub; Katia Jaton; Aline Wenger; Jacques Bille; Thierry Calandra; Guy Prod'hom
Journal:  BMC Infect Dis       Date:  2006-01-20       Impact factor: 3.090

3.  Detection of methicillin-resistance gene in Staphylococcus epidermidis strains isolated from patients in Al-Zahra Hospital using polymerase chain reaction and minimum inhibitory concentration methods.

Authors:  Ebtehaj Pishva; Seyed Asghar Havaei; Firouz Arsalani; Tahmineh Narimani; Amir Azimian; Mojtaba Akbari
Journal:  Adv Biomed Res       Date:  2013-03-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.